Insights

Strategic Partnerships vVARDIS has active and recent partnerships with Bupa Dental Care, Aspen Dental Group, Pearl AI, and CareQuest, indicating a strong appetite for distribution and co-innovation with large dental networks and tech providers. Leverage these connections to explore expanded rollout opportunities, co-marketing, and pilot programs in both traditional and AI-driven dental care workflows.

Global Expansion Recent financing of 85 million dollars and financing rounds with OrbiMed signal aggressive global expansion plans for Curodont repairs. This creates opportunity to position sales efforts around international clinics, dental groups, or regions prioritizing minimally invasive, regenerative care for early caries, with a focus on scale-up support and training.

Clinical Value Curodont Repair offers non-invasive, drill-free enamel remineralization supported by widespread publications and adoption by thousands of clinicians. Convert this clinical edge into sales conversations by targeting dental practices focused on preventive and conservative dentistry, highlighting faster patient throughput and oath of tooth preservation.

Digital & Analytics Synergy The tech stack includes platforms such as HubSpot Analytics, OneTrust, iCIMS, and partnerships with AI players like Pearl. This suggests readiness for CRM-driven multi-channel outreach, data-backed lead scoring, and training programs. Propose integrated marketing and sales enablement programs that align digital campaigns with clinical education.

Key Markets & Funding With revenue in the mid single-digit millions, substantial funding, and partnerships with large dental networks, focus sales efforts on mid-to-large dental groups and regional health plans that prioritize preventive dentistry and value-based care. Position Curodont as a scalable, cost-saving solution that reduces invasive procedures and supports patient retention.

Similar companies to vVARDIS

vVARDIS Tech Stack

vVARDIS uses 8 technology products and services including Microsoft Advertising, HubSpot Analytics, iCIMS, and more. Explore vVARDIS's tech stack below.

Media & News

vVARDIS's Email Address Formats

vVARDIS uses at least 4 email formats:
vVARDIS Email FormatsExamplePercentage
First.Last@vvardis.comJohn.Doe@vvardis.com
95%
First.MiddleLast@vvardis.comJohn.MichaelDoe@vvardis.com
2%
FirstMiddleLas@vvardis.comJohnMichaelDoe@vvardis.com
2%
FL@vvardis.comJD@vvardis.com
1%

Frequently Asked Questions

What is vVARDIS's official website and social media links?

Minus sign iconPlus sign icon
vVARDIS's official website is vvardis.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does vVARDIS generate?

Minus sign iconPlus sign icon
As of August 2026, vVARDIS's annual revenue is estimated to be $10M - $25M.

What is vVARDIS's NAICS code?

Minus sign iconPlus sign icon
vVARDIS's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does vVARDIS have currently?

Minus sign iconPlus sign icon
As of August 2026, vVARDIS has approximately 174 employees across 3 continents, including North America, Europe and South America. Key team members include Ceos & Founders & Owners: D. H., Chief Financial Officer: T. R. and Chief Digital Officer (cdo): L. F. K. Explore vVARDIS's employee directory with LeadIQ.

What industry does vVARDIS belong to?

Minus sign iconPlus sign icon
vVARDIS operates in the Medical Equipment Manufacturing industry.

What technology does vVARDIS use?

Minus sign iconPlus sign icon
vVARDIS's tech stack includes Microsoft Advertising, HubSpot Analytics, iCIMS, OneTrust, Zendesk, Microsoft 365, Sendinblue and Adobe Creative Suite.

What is vVARDIS's email format?

Minus sign iconPlus sign icon
vVARDIS's email format typically follows the pattern of First.Last@vvardis.com. Find more vVARDIS email formats with LeadIQ.

How much funding has vVARDIS raised to date?

Minus sign iconPlus sign icon
As of August 2026, vVARDIS has raised $87M in funding. The last funding round occurred on Apr 27, 2026 for $50M.

When was vVARDIS founded?

Minus sign iconPlus sign icon
vVARDIS was founded in 2019.
vVARDIS logo

vVARDIS

Medical Equipment ManufacturingZug, Switzerland51-200 Employees

vVARDIS is a Swiss medical device company that develops dental care products under the CURODONT brand to treat early-stage decay and stimulate enamel remineralization. Its flagship product, Curodont Repair, employs proprietary biomimetic peptide technology to arrest and reverse early caries by promoting enamel regeneration, with a non-invasive, quick application suitable for patients of all ages. The products are directed at dental professionals and clinics seeking a minimally invasive intervention to preserve natural tooth structure.

Based in Zug, Switzerland, vVARDIS was founded by Dr. Haley Abivardi and Dr. Goly Abivardi, drawing on more than 25 years of research and the founders' combined three decades of dental and entrepreneurial experience. Positioned in the medical equipment manufacturing sector, the company emphasizes regenerative, drill-free therapies designed to make caries treatment pain-free and accessible. In early 2025, vVARDIS announced a partnership with Aspen Dental Group to broaden access to its CURODONT offerings.

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2019
Employees
51-200

Section iconFunding & Financials

  • $87M

    vVARDIS has raised a total of $87M of funding over 4 rounds. Their latest funding round was raised on Apr 27, 2026 in the amount of $50M as a Private Equity.

  • $10M - $25M

    vVARDIS's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.